pharmaphorum Podcast

Bringing women’s health up to speed for 21st Century human healthcare

07 Dec 2023

Contributed by Lukas

In this latest instalment of the pharmaphorum podcast, web editor Nicole Raleigh speaks with David Solomon, CEO of Mithra Pharmaceuticals, about the c...

Creating a future where the healthcare ecosystem works for everyone

05 Dec 2023

Contributed by Lukas

In a new episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Ari Tulla, CEO and co-founder of Elo Health, about his ‘big visi...

Key themes from Frontiers Health 2023, with the pharmaphorum team

30 Nov 2023

Contributed by Lukas

In today’s podcast, Nicole and Eloise sit down with host Jonah Comstock to talk about some of what they saw and heard at the show, including how dig...

Reducing the stigma attached to psychedelics

28 Nov 2023

Contributed by Lukas

In a new episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Dr Sarah Bateup, therapy lead at Clerkenwell Health, a British sta...

How birth tissue donations are fuelling the cell therapy revolution

23 Nov 2023

Contributed by Lukas

On today’s podcast, host Jonah Comstock chats with Priya Baraniak, chief business officer and head of process development and manufacturing at Organ...

Immunometabolism: Providing a new era of targeted medicine

21 Nov 2023

Contributed by Lukas

In a new episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Neil Weir, CEO of Sitryx Therapeutics, a smaller biotech that spec...

Retaining the human element of AI within pharma and healthcare

16 Nov 2023

Contributed by Lukas

In this episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Venu Mallarapu, vice president of global strategy and operations at...

Resilience, empathy, and gratitude. A personal battle with breast cancer.

14 Nov 2023

Contributed by Lukas

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Nataliya Andreychuk, CEO of Viseven, about her personal battle with breast cancer...

The ‘elegant science’ in achieving the promise of ADCs

07 Nov 2023

Contributed by Lukas

In this week’s episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Raquel Izumi, chief operating officer and co-founder of Vi...

Understanding the importance of the whole person in clinical research

02 Nov 2023

Contributed by Lukas

In this episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with KimberLee Heidmann, executive vice president of patient experience ...

Why medical weight loss is more complicated than GLP-1s

27 Oct 2023

Contributed by Lukas

This week the podcast welcomes Dr Rekha Kumar, medical affairs lead at digital medical weight loss clinic Found. Kumar discusses how her practice has ...

Creating behavioural change through incremental, small steps

24 Oct 2023

Contributed by Lukas

In this latest episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Sarah Watters, senior consultant at Wellth, a company devote...

How AI can bolster each step of the clinical trial journey

19 Oct 2023

Contributed by Lukas

In today's podcast, brought to you by Syneos Health, host Jonah Comstock is joined by Baba Shetty, president of technology and data solutions at Syneo...

Focussing on finding value in health sciences marketing

17 Oct 2023

Contributed by Lukas

In this latest instalment of the pharmaphorum podcast, web editor Nicole Raleigh speaks with life sciences advisor Randall Hein, CEO of Heinsight LLC,...

How big pharma cares for its own

12 Oct 2023

Contributed by Lukas

On today’s podcast, host Jonah Comstock is joined by Jamie Eden, SVP of human resources at Boehringer Ingelheim, the world's largest private pharmac...

Embracing the challenges and opportunities of digital health

10 Oct 2023

Contributed by Lukas

In this new instalment of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Dominic James, global head of digital health innovation and ...

How AI and omnichannel are transforming pharma marketing

05 Oct 2023

Contributed by Lukas

In today's podcast, sponsored by Viseven, host Jonah Comstock welcomes Nataliya Andreychuk, Viseven's CEO, to talk about how AI is changing the world ...

Digital therapeutics at a turning point: What we heard at DtX East

03 Oct 2023

Contributed by Lukas

Pharmaphorum Editor in Chief Jonah Comstock is joined on the podcast this week by friend-of-the-pod Eugene Borukhovich, who in addition to serving as ...

Understanding and addressing care disparities in rare cancers

28 Sep 2023

Contributed by Lukas

In today's podcast, sponsored by Oracle, host Jonah Comstock is joined by Otavio Clark, vice president of oncology at Cerner Enviza, an Oracle company...

Turning drug development on its head

21 Sep 2023

Contributed by Lukas

In this instalment of the pharmaphorum podcast, host Jonah Comstock welcomes Alchemab CEO Young Kwon, whose company has a different approach: starting...

GLP-1 Weight loss drugs: An overview and update

14 Sep 2023

Contributed by Lukas

On today’s pharmaphorum podcast, Dr. Tim Church, chief medical officer at digital weight loss clinic Wondr Health joins Editor in Chief Jonah Comsto...

Biopharma’s rapid transition to omnichannel marketing

07 Sep 2023

Contributed by Lukas

In today’s episode, sponsored by Veeva, we’ll hear a roundtable discussion on this fascinating topic featuring Victoria Serra Gittermann, European...

Partnering for holistic care

31 Aug 2023

Contributed by Lukas

In a new episode of the pharmaphorum podcast, editor-in-chief Jonah Comstock speaks with Eugene Borukhovich, co-founder and COO of YourCoach Health, a...

Mapping the landscape of clinical trial regulation

25 Aug 2023

Contributed by Lukas

In today’s podcast, Medable Chief Science Officer Dr. Pamela Tenaerts joins host Jonah Comstock to discuss the current state of regulations in DCTs ...

Preparing for the tsunami of healthcare data approaching

15 Aug 2023

Contributed by Lukas

In a new pharmaphorum podcast, web editor Nicole Raleigh spoke with Michael Ibara, chief data officer at Elligo Health Research, discussing AI in clin...

Alzheimer’s drugs: An overview and update

10 Aug 2023

Contributed by Lukas

In the latest episode of the podcast, pharmaphorum Editor in Chief Jonah Comstock welcomes Dr. Alvaro Pascual-Leone, a neurology professor at Harvard ...

Suffering beyond physical effects: inequalities and taboos in prostate cancer

01 Aug 2023

Contributed by Lukas

In this episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with André Deschamps, formerly president of Europa Uomo, the voice of m...

Collaborative perseverance to bring change to medicine access

28 Jul 2023

Contributed by Lukas

Recently, pharmaphorum web editor Nicole Raleigh spoke with Herbert Altmann, head of commercialisation and access solutions Europe at PharmaLex, and C...

Botanicals in pharma: Potential and pitfalls

27 Jul 2023

Contributed by Lukas

In today’s podcast, Saad Harti, founder and CEO of Legacy Healthcare, joins Editor in Chief Jonah Comstock to discuss this exciting old, yet new...

Clinical trial diversity: An update

13 Jul 2023

Contributed by Lukas

Editor in Chief Jonah Comstock welcomes back returning guest Dr. Jennifer Jones-McMeans, divisional vice president for global affairs for Abbot’s va...

Changing personnel dynamics in the pharma world

06 Jul 2023

Contributed by Lukas

In this episode of the pharmaphorum podcast, brought to you by Advanced Clinical, Advanced Clinical’s SVP Strategic Resourcing Steve Mattas and VP o...

Retaining the human quality of healthcare in DTx

05 Jul 2023

Contributed by Lukas

As DTx Europe came to a close at the British Medical Association in London, pharmaphorum web editor Nicole Raleigh spoke with Digital Medicine Society...

Focusing on predictability and execution in digital trials

28 Jun 2023

Contributed by Lukas

Recently attending the Veeva R&D and Quality Summit in Madrid, pharmaphorum web editor Nicole Raleigh sat down with Veeva’s president of Europe, Chr...

Genetic testing update with 23andMe’s Noura Abul-Husn

16 Jun 2023

Contributed by Lukas

In the latest instalment of the pharmaphorum podcast, Editor in Chief Jonah Comstock is joined by Dr Noura Abul-Husn, VP of genomic health at 23andMe....

Headlines and hot topics from ASCO and BIO

09 Jun 2023

Contributed by Lukas

This week, pharmaphorum editor-in-chief Jonah Comstock headed to not one but two back-to-back events in the US. Starting with the American Society o...

The precision element at the heart of digital transformation

30 May 2023

Contributed by Lukas

On the final day of Reuters Pharma Barcelona back in March, web editor Nicole Raleigh sat down with Graphite Digital’s CEO, Rob Verheul. The company...

AI in drug development: A reality check

25 May 2023

Contributed by Lukas

In this episode of the pharmaphorum podcast, Editor in Chief Jonah Comstock catches up with Adityo Prakash, CEO of Verseon, to shed some light on what...

Epiphany moments in an industry starved of insights

22 May 2023

Contributed by Lukas

Back in March at Reuters Pharma Barcelona, pharmaphorum’s web editor Nicole Raleigh met up with CEO of Within3, Lance Hill. Having met up in Nice in...

A closer look at gene therapy with PTC Therapeutics

18 May 2023

Contributed by Lukas

 In the latest instalment of the pharmaphorum podcast, Editor in Chief Jonah Comstock connects with Kylie O’Keefe to talk about gene therapy in rar...

WWD: Ready, Set, Food! CEO, Daniel Zakowski

11 May 2023

Contributed by Lukas

On 21st June, London’s prestigious Royal Society of Medicine will play host to some of the sharpest minds in healthcare as they come together for th...

The Hidden Burden of Stigmatised Health Conditions

02 May 2023

Contributed by Lukas

Having any chronic health condition is complicated, difficult, and scary. But add in a cultural or social stigma and you create whole new levels of ch...

Creating healthier futures - Reuters Pharma Barcelona 2023

02 May 2023

Contributed by Lukas

In this latest mini pharmaphorum podcast, web editor Nicole Raleigh spoke with Tommy Bramley, SVP of global consulting at Amerisource Bergen, whilst a...

Inside the new world of healthcare data

20 Apr 2023

Contributed by Lukas

On today’s pharmaphorum podcast, Evidation’s Executive Chair of the Board Deborah Kilpatrick joins host Jonah Comstock to talk about healthcare da...

Restoring sensitivity to targeted therapies

14 Apr 2023

Contributed by Lukas

In this new episode of the mini pharmaphorum podcast, web editor Nicole Raleigh spoke with Simon Powell, CEO of Ribonexus, a new company put together ...

Insulin costs & pharma manufacturing

13 Apr 2023

Contributed by Lukas

In today’s pharmaphorum podcast, brought to you by Lannett Corporation, editor in chief Jonah Comstock first chats with Timothy Crew, CEO of Lannett...

What the low impact of Humira biosimilars teaches us about drug prices

06 Apr 2023

Contributed by Lukas

Almost everyone seems to agree that drug prices are too high. But that agreement stops when it comes to the question of why they’re so high, and to ...

Transforming healthcare: Nils Bottler and Paul Tunnah

30 Mar 2023

Contributed by Lukas

Angelini Ventures is a recently launched investment fund seeking companies that are transformational in healthcare. Founder of pharmaphorum and Health...

Challenges and opportunities with plasma-derived therapies

23 Mar 2023

Contributed by Lukas

For the newest pharmaphorum podcast, editor in chief Jonah Comstock welcomes Dr. Kristina Allikmets, SVP and head of R&D at Takeda’s plasma-derived ...

CinCor Pharma: A small pharma’s journey to acquisition

10 Mar 2023

Contributed by Lukas

In this episode of the pharmaphorum podcast, host Jonah Comstock welcomes Marc de Garidel, CEO of CinCor Pharma, which was just recently sold to Astra...

AI trends in 2023

02 Mar 2023

Contributed by Lukas

No matter what industry you’re in, artificial intelligence is a major topic around the water cooler. But while AI in popular culture may be at a pea...

Accelerating digital healthcare, with VITA

01 Mar 2023

Contributed by Lukas

At the beginning of February, pharmaphorum web editor Nicole Raleigh travelled to Rome to cover the inaugural VITA Accelerator demo day. After the eve...

Investing in healthcare’s future, with Paul Tunnah and Elia Stupka

17 Feb 2023

Contributed by Lukas

Angelini Ventures is a recently launched investment fund seeking companies that are transformational in healthcare. pharmaphorum founder and Healthwar...

Solving problems in pathology data, with Nathan Buchbinder

09 Feb 2023

Contributed by Lukas

 This time around on the pharmaphorum podcast, Editor in Chief Jonah Comstock chats with Nathan Buchbinder, cofounder and chief product officer at Pr...

How Moderna kept diversity in mind amid vaccine development

26 Jan 2023

Contributed by Lukas

In the newest episode of the pharmaphorum podcast, Editor in Chief Jonah Comstock speaks with Jameka Hill, senior director of clinical trial health eq...

Key themes from JP Morgan, with Paul Tunnah

12 Jan 2023

Contributed by Lukas

pharmaphorum Editor-in-Chief Jonah Comstock and pharmaphorum Founder Paul Tunnah headed to San Francisco this week for the JP Morgan conference, the a...

Cancer control in a time of crisis

05 Jan 2023

Contributed by Lukas

During The Economist’s 8th Annual World Cancer Series congress in Brussels last month, web editor Nicole Raleigh sat down to discuss the event and i...

The scattered seeds of the beginnings of change

30 Dec 2022

Contributed by Lukas

Speaking with Rob Verheul, CEO of Graphite Digital, at Anthropy 2022 at the Eden Project, pharmaphorum web editor Nicole Raleigh enjoyed a minute disc...

A few of the 2022’s biggest pharma trends

29 Dec 2022

Contributed by Lukas

As we close out the year, the pharmaphorum editorial team sits down together for a roundtable discussion of some of the biggest trends they’ve track...

Exploring the importance we play in our own health maintenance

23 Dec 2022

Contributed by Lukas

While at Anthropy 2022, pharmaphorum’s web editor Nicole Raleigh briefly spoke with Karyn Johnston, chief executive of East Cheshire Hospice, who ha...

Focusing on the evolution of biotechnology and R&D

22 Dec 2022

Contributed by Lukas

Following an invite to fly into Parma, Italy to witness first-hand the press launch of the considerable structure that is the Chiesi Group’s new €...

Innovations in Real-World Evidence (live from PharmStars)

15 Dec 2022

Contributed by Lukas

On today’s pharmaphorum podcast, host Jonah Comstock takes us to the PharmStars presentation last month at the Boston Seaport, with interviews condu...

Continuing to keep COVID-19 at bay

08 Dec 2022

Contributed by Lukas

Flying into London recently for the Jefferies Conference, Novavax’s EVP, chief commercial officer, and chief business officer John Trizzino, togethe...

Can VR technology make physical therapy fun

01 Dec 2022

Contributed by Lukas

In the newest episode of the pharmaphorum podcast, editor in chief Jonah Comstock chats with Gita Barry, EVP and GM of Immersive Healthcare at Penumbr...

Exploring a united vision for British pharma at Anthropy

28 Nov 2022

Contributed by Lukas

Anthropy 2022 brought climate change to industry in Cornwall in (a very wet and windy) early November, settling cosily into the truly eco-minded envir...

What we heard and saw at HLTH22, with Matthew Holt

24 Nov 2022

Contributed by Lukas

pharmaphorum Editor-in-Chief Jonah Comstock traveled to Las Vegas last week with thousands of other healthcare stakeholders for the HLTH 2022 conferen...

Disrupting the standard of healthcare for Bangladesh

18 Nov 2022

Contributed by Lukas

In this mini episode of the pharmaphorum podcast, web editor Nicole Raleigh spoke with Sylvana Sinha, founder, chair, and CEO of Praava Health, Bangla...

How immersive audio can be a therapeutic tool

17 Nov 2022

Contributed by Lukas

In this episode of the pharmaphorum podcast, Editor in Chief Jonah Comstock chats with Howard Rose, head of health and wellness at Spatial about immer...

A new hope in cachexia and an outsider’s view on pharma

10 Nov 2022

Contributed by Lukas

In the latest installment of the pharmaphorum podcast, Editor in Chief Jonah Comstock sits down with Russell Potterfield, CEO at Endevica Pharma. A bi...

Why is digital health so challenging for big tech?

03 Nov 2022

Contributed by Lukas

In this episode of the pharmaphorum podcast, host Jonah Comstock taps XIL Health’s Susan Lang to better understand why big tech’s ventures into he...

Live from Frontiers Health 2022 - the pharmaphorum podcast

27 Oct 2022

Contributed by Lukas

In this special, live edition of the pharmaphorum podcast, recorded at the conclusion of Frontiers Health 2022, pharmaphorum Editor in Chief Jonah Com...

Live from Reuters Pharma 2022 - the pharmaphorum podcast

20 Oct 2022

Contributed by Lukas

In mid-October, our Web Editor Nicole Raleigh and Deep Dive Editor Eloise McLellan traveled to Nice for the Reuters Pharma event. This special episo...

Building agile partner relationships at a vaccine-focused biotech

13 Oct 2022

Contributed by Lukas

In this episode of the pharmaphorum, Dr Paul Tunnah chats with Jeff Baxter, CEO of VBI Vaccines and Lee Taurman, executive vice president full service...

Understanding the tumour micro-environment – the pharmaphorum podcast

06 Oct 2022

Contributed by Lukas

Dr Marie-Louise Fjällskog, chief medical officer at Faron Pharmaceuticals, joins host Jonah Comstock for the pharmaphorum podcast this week to give u...

How a once-weekly insulin could disrupt diabetes management

22 Sep 2022

Contributed by Lukas

In the latest pharmaphorum podcast, Florian Baeres, Corporate Vice President for global medical affairs at Novo Nordisk, joins editor in chief Jonah C...

How these parents of a child with a rare disease are making precision medicine work for them

08 Sep 2022

Contributed by Lukas

In today’s pharmaphorum podcast, editor in chief Jonah Comstock invites Drs Zachary and Geri Landman to tell their daughter Lucy’s story and the s...

AI-derived cancer vaccines

25 Aug 2022

Contributed by Lukas

Today on the pharmaphorum podcast, Editor in Chief Jonah Comstock welcomes Hedi Ben Brahim and Eric Quéméneur, CEO and chief science officer respect...

Challenges and opportunities in the off-patent sector

11 Aug 2022

Contributed by Lukas

In the newest episode of the pharmaphorum podcast, Editor in Chief Jonah Comstock welcomes Rebecca Guntern, vice president of medicines for Europe at ...

Building a digital therapeutic for paediatric behavioural health opioids

28 Jul 2022

Contributed by Lukas

On the latest instalment of the pharmaphorum podcast, editor in chief Jonah Comstock hosts Dr Benny Alouf, chief medical officer at Limbix to discuss ...

Gene silencing and mRNA: breakthroughs and barriers

14 Jul 2022

Contributed by Lukas

On this week’s pharmaphorum podcast, editor in chief Jonah Comstock catches up with Dr. Marie Wikström Lindholm, SVP of molecular design at Sil...

Rethinking pharmaceutical pain management beyond opioids

05 Jul 2022

Contributed by Lukas

On the latest installment of the pharmaphorum podcast, editor in chief Jonah Comstock hosts Tony Mack, CEO at Virpax Pharmaceuticals, in the virtual s...

Why diverse clinical trials matter

16 Jun 2022

Contributed by Lukas

In this episode of the pharmaphorum podcast, editor in chief Jonah Comstock welcomes Dr. Jennifer Jones-McMeans, divisional vice president for global ...

Where pharma stands on patient centricity, engagement, and trust

06 Jun 2022

Contributed by Lukas

In the latest episode of the pharmaphorum podcast, editor in chief Jonah Comstock catches up with Pervaise Khan, Managing Director of Life Sciences, U...

How pharma can spur innovation and promote health equity in mental health

19 May 2022

Contributed by Lukas

In the newest episode of the pharmaphorum podcast, editor in chief Jonah Comstock speaks with Mohammed Issa, Vice President of Commercial at US Jansse...

Innovative solutions to the drug pricing crisis: the pharmaphorum podcast

29 Apr 2022

Contributed by Lukas

In the newest episode of the pharmaphorum podcast, Editor in Chief Jonah Comstock speaks with Dr Colin Banas, chief medical officer at DrFirst.   The...

Big data and how it can change the game in pharma: the pharmaphorum podcast

23 Mar 2022

Contributed by Lukas

In the latest episode of the pharmaphorum podcast, Editor in Chief Jonah Comstock speaks with Miruna Sasu, chief strategy officer of COTA and long-tim...

The year ahead in digital health and life sciences: the pharmaphorum podcast

10 Feb 2022

Contributed by Lukas

In the latest episode of the pharmaphorum podcast, Editor in Chief Jonah Comstock speaks with Jennifer Goldsack, CEO of the Digital Medicine Society (...

The evolution of clinical trials: the pharmaphorum podcast

14 Jan 2022

Contributed by Lukas

In the latest episode of the pharmaphorum podcast, Dr Paul Tunnah speaks to head of Patient Engagement at Syneos Health, Marie Emms, and Elligo Health...

Patient engagement processes: the pharmaphorum podcast

17 Dec 2021

Contributed by Lukas

This episode of the pharmaphorum podcast is the second in a limited series focused on patient engagement that’s being led clinician, consultant and ...

Real-world evidence and qualitative research: the ELICIT podcast

25 Nov 2021

Contributed by Lukas

In the first episode of the ELICIT podcast, a new series produced in partnership with Cerner Enviza, the guests discuss qualitative real-world evidenc...

Merck on trends in oncology: the pharmaphorum podcast

12 Nov 2021

Contributed by Lukas

Episode 45 of the pharmaphorum podcast heard from Dr Stuart Hill, how he’s seen the oncology landscape change and which of those he sees holding the...

Sandoz’s Pierre Bourdage on biosimilars: the pharmaphorum podcast

05 Nov 2021

Contributed by Lukas

In the latest episode of the podcast Dominic Tyer speaks with Pierre Bourdage, who’s global head of biopharmaceuticals at Sandoz about the big issue...

Patient engagement strategies: the pharmaphorum podcast

29 Oct 2021

Contributed by Lukas

This episode of the pharmaphorum podcast is the first in an occasional series focused on patient engagement that’s being led by Mark Duman, a clinic...

BMS’ Catherine Owen on pharma commercialisation: the pharmaphorum podcast

15 Oct 2021

Contributed by Lukas

Episode 42 of the pharmaphorum podcast heard from Catherine Owen, who’s senior vice president of major markets at Bristol Myers Squibb, about the fu...

Novartis’ Amit Nastik on COVID’s supply chain impact: the pharmaphorum podcast

04 Oct 2021

Contributed by Lukas

Episode 41 of the pharmaphorum podcast heard from Amit Nastik about the impact of COVID-19 on pharma supply chains and how he and his team mitigated d...

Virtual engagement and collaborations: the pharmaphorum podcast

22 Sep 2021

Contributed by Lukas

As the world passes the year and a half mark of the COVID-19 pandemic, the evolving experience of the ‘new normal’ environment across the healthca...

Biotech Insight podcast: Overcoming planning challenges in oncology

08 Sep 2021

Contributed by Lukas

The first episode of Kantar Health’s new Biotech Insight podcast takes aim at the planning and forecasting challenges that biotechnology companies f...

Vertex senior country manager Nicola Massey: the pharmaphorum podcast

23 Aug 2021

Contributed by Lukas

In the latest episode of the podcast Dominic Tyer speaks with Nicola Massey, who’s Vertex’s senior country manager in the UK and Ireland.

Regenerative medicine and COVID: the pharmaphorum podcast

13 Aug 2021

Contributed by Lukas

In the latest episode of the podcast Dominic Tyer speaks with Dr Maria Ines ‘Mari’ Mitrani, chief science officer at the clinical-stage biopharma...

Pharmacy and clinical research: the pharmaphorum podcast

30 Jun 2021

Contributed by Lukas

In the latest episode of the pharmaphorum podcast, pharmaphorum’s web editor Catherine Longworth speaks to Gerald Finken, the founder and CEO of Rx...

Pharma’s post-COVID prospects: the pharmaphorum podcast

28 May 2021

Contributed by Lukas

In this latest podcast, pharmaphorum spoke to Andrew Meade, life sciences lead UK and Ireland at Accenture, about the trends that emerged in this year...